Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
13F holders, Q1 2024 (March 31)4holders
$1.61avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Ironwood Pharmaceuticals (irwd 1.5 06/15/26) in their 13F filings. The largest holders were Bank of New York Mellon Corp ($202K), Cerity Partners LLC ($174K) and Cetera Investment Advisers ($36K).
- Company
- Ironwood Pharmaceuticals (irwd 1.5 06/15/26)
- CUSIP
- 46333XAH1
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $239K |
| Exits | 2 | $4.0M |
Ownership 4 holders
| Bank of New York Mellon Corp | 0.00% | New | 200,000 | $202K |
| Cerity Partners LLC | 0.00% | Reduce -49.6% | 18,153 | $174K |
| Cetera Investment Advisers | 0.00% | New | 36,000 | $36K |
| Northwestern Mutual Wealth Management Co. | 0.00% | No change | 6,000 | $6K |
"% of holder's portfolio" is IRONWOOD PHARMACEUTICALS (IRWD 1.5 06/15/26)'s weight in each manager's 13F, not the share of Ironwood Pharmaceuticals (irwd 1.5 06/15/26) the manager owns.